Pathway analysis identified several genes, including Cyclin E, that were frequently co-expressed with POLQ. Cyclin E over expression has been identified as being associated with an adverse outcome in breast cancer patients [26]. This evidence concerns the gene CCNE1 and breast carcinoma.